A Centers for Disease Control and Prevention advisory panel voted to recommend the use of novavax Inc.’s Covid-19 Vaccine, One of the Final Barriers Before the Shot Is Made Widely Available in the US
Members of the Advisory Committee on Immunization Practices voted unanimously 12-0 on Tuesday to recommend Novavax’s vaccine for adults 18 years of age and older.